PMU67 - COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN THE UNITED KINGDOM
Abstract
Authors
CT Storck B Schweikert ÖP Åkerborg G Kumar DH Nott S Kiri C Sapin S Hartz